Year: 2024

Sezzle to Participate in Upcoming Investor Conference

Written by Customer Service on December 23, 2024. Posted in Public Companies.

Minneapolis, MN, Dec. 23, 2024 (GLOBE NEWSWIRE) — Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Sezzle, a leader in the flexible payments industry, is pleased to announce that the Company will participate in the following investor conference:On January 16, 2025, Charlie Youakim (Chairman and CEO), Karen Hartje (Chief Financial Officer), and Lee Brading (SVP, Corporate Development and Investor Relations) will attend the 27th Annual Needham Growth Conference. Contact InformationLee Brading, CFA Investor Relations +1 651 240 6001 InvestorRelations@sezzle.com Erin Foran Media Enquiries +1 651 403 2184 Erin.Foran@sezzle.comAbout Sezzle Inc. Sezzle is a forward-thinking company committed to financially empowering the next generation. Through its purpose-driven payment platform, Sezzle enhances consumer purchasing...

Clockwise Announces Yearly Distributions on $TIME

Written by Customer Service on December 23, 2024. Posted in Dividend Reports And Estimates.

NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) — Clockwise today announced yearly distributions on the Clockwise Core Equity & Innovation ETF (TIME). Distribution as of 12/20/2024ETFTicker Distributionper Share Ex-Date RecordDate PaymentDateTIME $3.9355 12/23/2024 12/23/2024 12/26/2024TIME, launched in partnership with Tidal Investments LLC, offers an adaptive approach to innovation investing. Capitalizing on trends in AI – and technology more broadly – serve as the guiding principle, while balancing opportunities and volatility by staying attuned to economic cycles. As an actively managed ETF, Clockwise adjusts its positions and position sizes in response to market and economic changes, all while keeping an eye on long-term technological advancements. About Tidal Investments LLC Formed by ETF industry pioneers...

Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic

Written by Customer Service on December 23, 2024. Posted in Public Companies.

AI Components for Electronic Data Capture and Patient Monitoring to be Integrated into Phase 2 HOUSTON, TX, Dec. 23, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS) of the brain, is pleased to announce the launch of Phase 1 of its proprietary virtual clinic. The virtual clinic will utilize artificial intelligence (AI) and Nexalin’s new Electronic Data Capture (EDC) platform and Patient Monitoring System (PMS). This AI ecosystem is designed to allow the entire clinical trial process—and ultimately the treatment experience—to be conducted virtually in the privacy of patients’ homes while providing physicians with real-time digital data related to the patient’s treatment experience. This innovative AI platform is being designed...

Real Matters to Announce First Quarter Fiscal 2025 Financial Results on January 30, 2025

Written by Customer Service on December 23, 2024. Posted in Public Companies.

TORONTO, Dec. 23, 2024 (GLOBE NEWSWIRE) — Real Matters Inc. (“Real Matters”), a leading network management services provider for the mortgage lending and insurance industries, will announce its first quarter fiscal 2025 financial results via news release on Thursday, January 30, 2025, before market open. Conference Call and Webcast A conference call to review the results will take place at 10:00 a.m. (ET) on Thursday, January 30, 2025, hosted by Chief Executive Officer Brian Lang and Chief Financial Officer Rodrigo Pinto. An accompanying slide presentation will be posted to the Investor Relations section of our website shortly before the call. To access the call:Participant Local (Toronto): (289) 819-1520 Participant Toll Free Dial-In Number: 1-800-549-8228 Conference ID: 15714To listen to the live webcast of the call:Go...

BOLLORÉ : INCREASE IN THE PRICE AND EXCHANGE RATIO OF PUBLIC BUYOUT OFFERS FOLLOWED BY MANDATORY SQUEEZE-OUTS ON THE SHARES OF COMPAGNIE DU CAMBODGE, FINANCIÈRE MONCEY AND SOCIÉTÉ INDUSTRIELLE ET FINANCIÈRE DE L’ARTOIS

Written by Customer Service on December 23, 2024. Posted in Mergers And Acquisitions.

BOLLORÉ PRESS RELEASE December 23, 2024 INCREASE IN THE PRICE AND EXCHANGE RATIO OF PUBLIC BUYOUT OFFERS FOLLOWED BY MANDATORY SQUEEZE-OUTS ON THE SHARES OF COMPAGNIE DU CAMBODGE, FINANCIÈRE MONCEY AND SOCIÉTÉ INDUSTRIELLE ET FINANCIÈRE DE L’ARTOIS Bolloré SE decided today to raise the price and the exchange ratio in Universal Music Group (UMG) shares of the public buyout offers followed by mandatory squeeze-outs announced on September 12, 2024, for Compagnie du Cambodge, Financière Moncey and Société Industrielle et Financière de l’Artois shares as follows:for Bolloré SE’s tender offer on Compagnie du Cambodge:Cash offer: EUR 110 per Compagnie du Cambodge share, representing an increase of 18.28% compared to the initial price of EUR 93; Exchange offer: 4.69 UMG shares for 1 Compagnie du Cambodge share, compared to the initial exchange...

FOXO TECHNOLOGIES INC. ANOUNCES DETAILS OF ITS 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 31, 2024

Written by Customer Service on December 23, 2024. Posted in Public Companies.

MINNEAPOLIS, MN, Dec. 23, 2024 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), will hold its 2024 Annual General Meeting of its Shareholders at 9:30 am CST on Tuesday, December 31, 2024. The Annual General Meeting will be a completely virtual meeting of its stockholders, which will be conducted via live webcast. You will be able to attend the Annual Meeting online, vote and submit your questions during the Annual Meeting by first registering at https://web.viewproxy.com/FOXO/2024 Shareholders of record on December 19, 2024, will be entitled to vote on the proposals. All shareholder votes are important. The Board of Directors asks that all shareholders vote in favor of the proposals listed on the Proxy Card filed as part of the Definitive Proxy Statement filed with the Securities and Exchange...

Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment

Written by Customer Service on December 23, 2024. Posted in Public Companies.

PRINCETON, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced the next CEO Corner segment has been published on the Company’s website. As part of the CEO Corner segment, Pankaj Mohan, Ph.D., Founder and Chief Executive Officer of Sonnet, highlighted the Company’s key accomplishments for calendar year 2024 and the targeted value-driving milestones in calendar year 2025. The CEO Corner is now accessible on the Company’s website here. Segments on the CEO Corner platform will be accessible on the Company’s website (www.sonnetbio.com) for 90 days. About Sonnet BioTherapeutics Holdings, Inc. Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform...

Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share

Written by Customer Service on December 23, 2024. Posted in Mergers And Acquisitions.

SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) — Singular Genomics Systems, Inc. (Nasdaq: OMIC) (“Singular Genomics” or the “Company”), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it has entered into a definitive merger agreement whereby an affiliate of Deerfield Management Company, L.P. will acquire Singular Genomics in an all-cash transaction for $20.00 per share. The $20.00 per share represents 254% premium to the last closing share price for Singular’s common stock prior to the September 12, 2024 public disclosure of Deerfield’s initial acquisition proposal. The Singular Genomics Board of Directors formed a special committee composed entirely of independent and disinterested directors (the “Special Committee”) to evaluate...

Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement

Written by Customer Service on December 23, 2024. Posted in Mergers And Acquisitions.

Inmagene Biopharmaceuticals is a clinical stage company focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody with an extended half-life and a silenced ADCC function The transaction is expected to result in approximately $175 million to support further development of IMG-007, including $75 million from an oversubscribed Private Placement that will close immediately following the merger The Financing includes both new investors such as Deep Track Capital, Foresite Capital, RTW Investments, and existing Ikena investors such as BVF Partners L.P., Blue Owl Healthcare Opportunities, Omega Funds, and OrbiMed The transaction is expected to close in mid-2025 BOSTON and SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,”) and Inmagene Biopharmaceuticals (“Inmagene”) announced they...

FlexShopper Announces Record Initial Holiday Season Results

Written by Customer Service on December 23, 2024. Posted in Earnings Releases And Operating Results.

Robust October and November 2024 results driven by the continued success of FlexShopper’s direct-to-consumer and business-to-business growth strategies Based on strong October and November 2024 performance, management expects the fourth quarter of 2024 to exceed financial results for the fourth quarter of 2023 BOCA RATON, Fla., Dec. 23, 2024 (GLOBE NEWSWIRE) — FlexShopper, Inc. (Nasdaq: FPAY), a prominent national online lease-to-own retailer and payment solutions provider, today announced record initial holiday season financial results, as the Company benefits from the continued success of its direct-to-consumer (DTC) and business-to-business (B2B) growth strategies. For the first two months of the 2024 fourth quarter, compared to the same two-month period in 2023, lease gross revenue increased 15%, and lease net revenue increased...

Year: 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals